Fetal arrhythmias: The Saint-Justine hospital experience

Prenatal Diagnosis

Volumn 24, Issue 13, 2004, Pages 1068-1080

  Fouron, Jean Claude ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Arrhythmia; Doppler; Foetus

Indexed keywords

AMIODARONE; DIGOXIN; PROPRANOLOL; SOTALOL;

ASCENDING AORTA; ATRIOVENTRICULAR BLOCK; ATRIOVENTRICULAR CONDUCTION; ATRIOVENTRICULAR DISSOCIATION; CARDIOMYOPATHY; DOPPLER ECHOGRAPHY; DOPPLER FLOWMETRY; EXTRASYSTOLE; FETUS; FETUS HEART RATE; HEART ARRHYTHMIA; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FLUTTER; HEART RATE VARIABILITY; HEART VENTRICLE EXTRASYSTOLE; HUMAN; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; SINUS BRADYCARDIA; SINUS RHYTHM; SINUS TACHYCARDIA; SUPERIOR CAVA VEIN; SUPRAVENTRICULAR PREMATURE BEAT; SUPRAVENTRICULAR TACHYCARDIA; TACHYCARDIA;

ARRHYTHMIA; BRADYCARDIA; ECHOCARDIOGRAPHY, DOPPLER; FETAL DISEASES; HUMANS; TACHYCARDIA; ULTRASONOGRAPHY, PRENATAL;

EID: 11144224803     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.1064     Document Type: Review

References (38)

1. Andelfinger G, Fouron JC, Sonesson SE, Proulx F. 2001. Reference values for time intervals between atrial and ventricular contractions of the foetal heart measured by two Doppler techniques. Am J Cardiol 88(12): 1433-1436.
2. Barrington KJ. 2001. The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs. BMC Pediatr 1: 1.
3. Batra A, Silka MJ. 2000. Ventricular arrhythmias. Prog Pediatr Cardiol 11: 39-45.
4. Baud O, Foix-L'Helias L, Kaminski M, et al. 1999. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 341: 1190-1196.
5. Baud O, Laudenbach V, Evrard P, Gressens P. 2001. Neurotoxic effects of fluorinated glucocorticoid preparations on the developing mouse brain: role of preservatives. Pediatr Res 50: 706-711.
6. Benditt DG, Pritchett ELC, Smith WM, Gallagher JJ. 1979. Ventriculoatrial intervals: diagnostic use in paroxysmal supraventricular tachycardia. Ann Intern Med 91: 161-166.
7. Bolens M, Friedli B. 1990. Junctional ectopic tachycardia with a benign course in a premature infant. Pediatr Cardiol 11: 216-218.
8. Buyon J, Roubey R, Swersky S, et al. 1988. Complete congenital heart block: risk of occurrence and therapeutic approach to prevention. J Rheumatol 15: 1104-1108.
9. Costedoat-Chalumeau N, Amoura Z, Le Thi Hong D, et al. 2003. Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block. Ann Rheum Dis 62: 1010-1012.
10. Coumel P, Fidelle JE, Attuel P, et al. 1976. Congenital bundle-of-his focal tachycardias. Cooperative study of 7 cases. Arch Mal Coeur Vaiss 69: 899-909.
11. Dancea A, Fouron JC, Miro J, Skoll A, Lessard M. 2000. Correlation between electrocardiographic and ultrasonographic time-interval measurements in the foetal Iamb heart. Pediatr Res 47: 324-328.
12. Donofrio MT, Gullquist SD, O'Connell NG, Redwine FO. 1999. Foetal presentation of congenital long QT syndrome. Pediatr Cardiol 20(6): 441-444.
13. Erkkola R, Lammintausta R, Liukko P, Anttila M. 1982. Transfer of propanolol and sotalol across the human placenta. Their effect on maternal and foetal plasma renin activity. Acta Obstet Gynecol Scand 61: 31-34.
14. Fisher DJ, Gross DM, Garson A Jr. 1983. Rapid sinus tachycardia: differentiation from supraventricular tachycardia. Am J Dis Child 137: 164-166.
15. Fouron JC, Fournier A, Proulx F, et al. 2003. Management of foetal tachyarrhythmia based on superior vena cava/aorta Doppler flow recordings. Heart 89: 1211-1216.
16. Fouron JC, Proulx F, Gosselin J, Infante-Rivard C. 2001. Investigation des arythmies fœtales par l'enregistrement simultané des vélocités sanguines dans l'aorte ascendante et la veine cave supérieure. Arch Mal Coeur Vaiss 94: 1063-1071.
17. Fouron JC, Proulx F, Miró J, Gosselin J. 2000. Doppler and M-mode ultrasonography to time foetal atrial and ventricular contractions. Obstet Gynecol 96: 732-736.
18. Glickstein JS, Buyon J, Friedman D. 2000. Pulsed Doppler echocardiographic assessment of the foetal PR interval. Am J Cardiol 86: 236-239.
19. Gross KR, Petty RE, Lum VL, Allen RC, 1989. Maternal autoantibodies and foetal disease. Clin Exp Rheumatol 7: 651-657.
20. Hofbeck M, Ulmer H, Beinder E, Sieber E, Singer H. 1997. Prenatal findings in patients with prolonged QT interval in the neonatal period. Heart 77(3): 198-194.
21. Houyel L, Fournier A, Ducharme G, Chartrand C, Davignon A. 1992. Electrophysiologic effects of sotalol on the immature mammalian heart. J Cardiovasc Pharmacol 19: 134-139.
22. Jaeggi ET, Fouron JC, Fournier A, van Doesburg NH, Drblik SP, Proulx F. 1998. Ventriculoatrial time interval measured on M-mode echocardiography: a determining element in diagnosis, treatment, and prognosis of foetal supraventricular tachycardia. Heart 79: 582-587.
23. Jaeggi ET, Silverman ED, Yoo SJ, Kingdom J. 2004. Is immunemediated complete foetal atrioventricular block reversible by transplacental dexamethasone therapy? Ultrasound Obstet Gynecol 23: 602-605.
24. Kleinman CS, Nehgme RA. 2004. Cardiac arrhythmias in the human foetus. Pediatr Cardiol 25(3): 234-251(E pub ahead of print).
25. Ko JK, Deal BJ, Strasnburger JF, Woodrow Benson D. 1992. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol 69: 1028-1032.
26. Ludomirsky A, Garson A Jr. 1990. Supraventricular syndromes. In Pediatric Arrhythmias: Electrophysiology and Pacing, Gillette PC, Garson A, Jr (eds). W.B. Saunders: Philadelphia, PA; 380-426.
27. Nield LE, Silverman ED, Taylor GP, et al. 2002. Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis. Circulation 105: 843-848.
28. Olàh KS, Gee H. 1991. Foetal heart block associated with maternal anti-Ro (SS-A) antibody (current management). A review. Br J Obstet Gynaecol 98(8): 751-755.
29. Pernot C, Cloez JL, Khalife K, Hda A, Marcon F. 1984. Supraventricular arrhythmia in newborn infants and interatrial septal aneurysm. Arch Fr Pediatr 41: 21-25.
30. Phillipos EZ, Robertson MA, Still KD. 1994. The echocardiographic assessment of the human foetal foramen ovale. J Am Soc Echocardiogr 7: 257-263.
31. Rein AJ, Simcha A, Ludomirsky A, Appelbaum A, Uretzky G, Tamir I. 1985. Symptomatic sinus bradycardia in infants with structurally normal heart. J Pediatr 107: 724-727.
32. Salomonsson S, Ottosson L, Säfsten P, et al. 2004. Cloning and characterization of two human Ro52-specific monoclonal auto-antibodies directed towards a domain associated with congenital heart block. J Autoimmunity 22: 167-177.
33. Schade RP, Stoutenbeek P, de Vries LS, Meijboom EJ. 1999. Neurological morbidity after foetal supraventricular tachyarrhythmia. Ultrasound Obstet Gynecol 13: 43-47.
34. Scott JS, Maddison PJ, Taylor PV, Esscher E, Scott O, Skinner P. 1983. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med 309: 209-212.
35. Sonesson SE, Salomonsson S, Jacobsson LA, Bremme K, Wahren-Herlenius M. 2004. Signs of first-degree heart block occur in one-third of foetuses of pregnant women with anti-SSA/Ro52-kd antibodies. Arth Rheumatism 50: 1253-1261.
36. Taylor PV, Taylor KF, Norman A, Griffiths S, Scott JS. 1988. Prevalence of maternal Ro (SS-A) and La (SS-B) autoantibodies in relation to congenital heart block. Br J Rheumatol 27: 128-132,
37. Van Hare GF, Stanger P. 1991. Ventricular tachycardia and accelerated ventricular rhythm presenting in the first month of life. Am J Cardiol 67: 42-45.
38. Villain E, Vetter VL, Garcia JM, Herre J, Cifarelli A, Garson A Jr. 1990. Evolving concepts in the management of congenital junctional ectopic tachycardia. A multicenter study. Circulation 81: 1544-1549.